Literature DB >> 8596869

Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures.

J A Kaufman1, S C Geller, A C Waltman.   

Abstract

Gadopentetate dimeglumine diluted 1:1 with 0.9% normal saline was used as the radiographic contrast agent in two patients with azotemia who underwent peripheral vascular interventional procedures. The patients had no evidence of contrast material-induced renal failure after the procedures. The radiographic attenuation of the diluted gadopentetate dimeglumine was equivalent to diatrizoate meglumine diluted to 40 mg iodine per milliliter. Gadopentetate dimeglumine is an alternative radiographic contrast material for azotemic patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596869     DOI: 10.1148/radiology.198.2.8596869

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Cerebral 3D-Gadolinium-DSA in a Patient with Renal Insufficiency Presenting a Subarachnoid Haemorrhage.

Authors:  M Jacamon; F Bonneville; A Robert; J Ferreira; J F Bonneville
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

2.  Gadopentetate dimeglumine as a contrast agent in common carotid arteriography.

Authors:  W K Erly; J Zaetta; G T Borders; H Ozgur; D R Gabaeff; R F Carmody; J Seeger
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 3.825

3.  Iodine contrast iso-attenuating with diagnostic gadolinium doses in CTA and angiography results in ultra-low iodine doses. A way to avoid both CIN and NSF in azotemic patients?

Authors:  Ulf Nyman; Barbara Elmståhl; Håkan Geijer; Peter Leander; Torsten Almén; Mats Nilsson
Journal:  Eur Radiol       Date:  2010-08-29       Impact factor: 5.315

4.  Gadolinium-enhanced CT angiography of the circle of Willis and neck.

Authors:  John W Henson; Raul G Nogueira; Diego J Covarrubias; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 5.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.